Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-047403
Filing Date
2007-03-06
Accepted
2007-03-06 16:44:30
Documents
13
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1133678
2 FORM OF WARRANT TO PURCHASE dex49.htm EX-4.9 66240
3 SUMMARY OF DIRECTOR COMPENSATION dex106.htm EX-10.6 3220
4 SUMMARY OF 2007 BONUS TARGETS dex107.htm EX-10.7 4577
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANT dex231.htm EX-23.1 2154
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RULE 13A-14(A) dex311.htm EX-31.1 9948
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULE 13A-14(A) dex312.htm EX-31.2 9995
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3269
9 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3271
11 GRAPHIC g62288g39k97.jpg GRAPHIC 52419
12 GRAPHIC g62288g68f00.jpg GRAPHIC 37125
13 GRAPHIC g62288g78m69.jpg GRAPHIC 4734
14 GRAPHIC g62288g96y73.jpg GRAPHIC 43159
  Complete submission text file 0001193125-07-047403.txt   1427593
Mailing Address
Business Address 4222 EMPEROR BLVD SUITE 350 DURHAM NC 27703 919-941-5206
ICAGEN INC (Filer) CIK: 0000902622 (see all company filings)

EIN.: 561785001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50676 | Film No.: 07675326
SIC: 2834 Pharmaceutical Preparations